baber/WOPTO huggingface dataset:
Patent CA-2682746-A1 (CA)
Inventor: PARSONS IAN CHRISTOPHER
IPC: G01N33/68
Filed: 2008-04-15
Abstract: The present disclosure provides nuclear magnetic resonance (NMR) methods for characterizing mixtures of N-linked glycans. Without limitation, methods of the present disclosure may be useful in characterizing monosaccharide composition, branching, fucosylation, sulfation, phosphorylation, sialylation linkages, presence of impurities and/or efficiency of a labeling procedure (e.g., labeling with a fluorophore such as 2-AB). In certain embodiments, the methods can be used quantitatively. In certain embodiments, the methods can be combined with enzymatic digestion to further characterize glycan mixtures.
Patent CA-2684196-A1 (CA)
Title: Electrical insulating layers, uv protection, and voltage spiking for electro-active diffractive optics
Inventor: CLARKE ROGER
IPC: G02C7/02
Filed: 2008-03-05
Abstract: An electro-active lens has a first substrate with a surface relief diffractive topological profile and a second substrate positioned opposite to the first substrate having a substantially smooth topological profile. A first electrode is positioned along the surface relief diffractive topological profile of the first substrate and a second electrode is positioned between the first electrode and the second substrate. The smallest distance between the electrodes is less than or equal to about 1 micron An electro-active material is positioned between the first and second electrodes and a first insulating layer is positioned between the first and second electrodes.
Patent CA-2684485-A1 (CA)
Inventor: NGUYEN SCOTT VINH
IPC: E21B36/00
Filed: 2008-04-18
Abstract: A heating system for a subsurface formation includes an electrical conductor and an insulation layer at least partially surrounding the electrical conductor. A jacket that includes ferromagnetic material at least partially surrounds the insulation layer. The outside surface of the jacket is configured to be at little or no electric potential while the electrical conductor is conducting electricity and while the jacket is at temperatures below the Curie temperature of the ferromagnetic material.
Patent CA-2685570-A1 (CA)
Title: Therapeutic compounds
Inventor: JENKINS THOMAS E
IPC: A61P25/20
Filed: 2008-05-08
Abstract: A (-)-stereoisomer of formula (I): [insert formula (I) wherein X is H or F; or a pharmaceutically acceptable salt or prodrug thereof, useful as an anesthetic.
Patent CA-2687385-A1 (CA)
Inventor: TALEUX NELLIE
IPC: A61K31/198
Filed: 2008-05-16
Abstract: The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3 ',5 ',3 -triiodothyronine (rT3), a rT3 derived hormone, or a precursor of rT3, such as T4 in association with a molecule susceptible to promote the formation of rT3, in association with a pharmaceutically acceptable vehicle.
Patent CA-2687889-A1 (CA)
Title: Augmentation de la luminance des del par retroreflexion speculaire, en utilisant des collimateurs qui echappent a la limite d'etendue
Inventor: FALICOFF WAQIDI
IPC: F21S6/00
Filed: 2008-05-21
Abstract: la réflectivité diffuse d'une source à DEL est utilisée pour recycler une partie de son émission, ce qui permet au luminaire d'échapper à la limite d'étendue. Les rétroréflecteurs interceptent les rayons destinés à la partie externe de l'ouverture du luminaire, qui peut ainsi être tronquée. L'ouverture réduite résultante a la même largeur de faisceau que l'original complet, mais avec un moindre flux du fait des pertes liées au recyclage. Une réduction à la moitié de la surface originale est possible.
Patent CA-2689901-A1 (CA)
Title: Sliding door interlocking system
Inventor: MCDANIEL KYLE A
IPC: E06B3/46
Filed: 2010-01-12
Abstract: A pair of interlocking bi-parting sliding doors includes a first sliding door and a second sliding door, wherein the first sliding door has a first meeting stile that includes a first side portion for maintaining a door glass panel and a first mating side portion for engaging the second sliding door, wherein the first mating side portion includes a plurality of recessed zones, and wherein the second sliding door has a second meeting stile that includes a second side portion for maintaining a door glass panel and a second mating side portion for engaging the first mating side portion of the first sliding door, wherein the second mating side portion includes a plurality of extensions, wherein when the first sliding door and the second sliding door are in a closed position, the plurality of extensions interlock with the plurality of recessed zones.
Patent CA-2690299-A1 (CA)
Inventor: KNUST HENNER
IPC: A61K31/551
Filed: 2008-06-04
Abstract: The present invention relates to a compound of Formula (I) wherein R1 is hydrogen or lower alkyl; is hydrogen, fluoro, hydroxy or lower alkyl; R3 is hydrogen or lower alkyl; R4 is -CHR5-A  R5 is hydrogen, lower alkyl, fluoro, CF3, CH2OH or cycloalkyl; A is aryl or heteroaryl, which rings are unsubstituted or substituted by (R6)o; R6 may be the same or not when o is more than one, and is heteroaryl, lower alkyl, lower alkoxy, cyano, halogen, lower alkyl substituted by halogen, lower alkoxy substituted by halogen or NR7R8; o is 1, 2 or 3; R7, R8 are independently hydrogen or lower alkyl; R9 is lower alkyl; R10 is lower alkyl, lower alkoxy or halogen; n is 1 or 2; m is 1 or 2; or to a pharmaceutically suitable acid addition salt thereof. The invention includes all sterioisomeric forms, including individual diastereoisomers and enantiomers of the compound of Formula (I) as well as racemic and non-racemic mixtures thereof. It has been found that the present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
Patent CA-2691400-A1 (CA)
Inventor: SCHALLHORN BRIAN
IPC: A23G9/38
Filed: 2007-06-12
Abstract: A frozen confection having improved nutritional value namely improved protein, omega essential fatty acids, energy and mineral and vitamin levels. An improved method of manufacture of a frozen confection that is simplified and does not require pasteurization thereby providing improved shelf life.
Patent CA-2692817-A1 (CA)
Inventor: BROWN DANIEL R
IPC: H04L9/30
Filed: 2008-07-09
Abstract: A method of compressing a cryptographic value. The method comprising the steps of: (a) selecting a secret value; (b) performing a cryptographic operation on the secret value to generate the cryptographic value; (c) determining whether the cryptographic value satisfies the pre-determined criteria; and (d) repeating the sequence of steps starting at step (a) until the cryptographic value satisfies the pre-determined criteria.
Patent CA-2695420-A1 (CA)
Inventor: NATT FRANCOIS JEAN-CHARLES
IPC: C12Q1/68
Filed: 2008-08-21
Abstract: The invention provides methods and compositions for detecting and/or quantifying nucleic acid oligonucleotides.  These methods and compositions are useful for detecting and quantifying diagnostic and/or therapeutic synthetic target oligonucleotides, such as aptamers, RNAi, siRNA, antisense oligonucleotides or ribozymes in a biological sample.
Patent CA-2698743-A1 (CA)
Inventor: BOONE SCOTT
IPC: E21B7/10
Filed: 2008-09-19
Abstract: Methods and systems for drilling to a target location include a control system that receives an input comprising a planned drilling path to a target location and determines a projected location of a bottom hole assembly of a drilling system. The projected location of the bottom hole assembly is compared to the planned drilling path to determine a deviation amount. A modified drilling path is created to the target location as selected based on the amount of deviation from the planned drilling path, and drilling rig control signals that steer the bottom hole assembly of the drilling system to the target location along the modified drilling path are generated.
Patent CA-2700074-A1 (CA)
Inventor: ZEIER ALEXANDER
IPC: G06F17/30
Filed: 2008-09-22
Abstract: In one embodiment the present invention includes a relational database management system component and a column-oriented data processing component. The relational database system component stores database information in a row format. The column-oriented data processing component stores the database information in a column format. In response to a database update request, the relational database management system component updates the database information stored in the row format; the relational database management system component notifies the column-oriented data processing component of the database update request; and the column-oriented data processing component updates the database information stored in said column format. In response to a query request, the column-oriented data processing component generates a query response based on the database information stored in said column format. In this manner, an embodiment of the present invention is able to generate up-to-date reports without the need for extraction, translation and loading procedures.
Patent CA-2700179-A1 (CA)
Title: Nanoparticules
Inventor: PICKETT NIGEL
IPC: C09K11/88
Filed: 2008-09-26
Abstract: L'invention porte sur une nanoparticule comportant un noyau d'un premier matériau et une couche d'un deuxième matériau. L'un des deux matériaux est un matériau semi-conducteur comprenant des ions des groupes 12 et 15 de la classification périodique et l'autre matériau est un oxyde métallique comprenant des ions métal sélectionnés parmi les groupes 1 à 12, 14 à 15 de la classification périodique. L'invention porte également sur des méthodes de préparation de ces particules. L'invention porte en outre sur une nanoparticule comportant un noyau d'un premier matériau et une couche d'un deuxième matériau déposée sur ledit noyau, l'un des deux matériaux étant un matériau semi-conducteur et l'autre matériau étant un oxyde d'un métal sélectionné parmi l'un des groupes 3 à 10 de la classification périodique.
Patent CA-2700242-A1 (CA)
Title: Use of a combination of an opioid agonist and an opioid antagonist for the treatment of crohn's disease and the symptoms associated with crohn's disease
Inventor: BENNETT-KERR JO
IPC: A61K31/485
Filed: 2008-09-25
Abstract: The present invention is concerned with the use of combinations of opioid agonists and antagonists for treating Crohn's disease.
Patent CA-2700598-A1 (CA)
Title: Nitrogen-containing heterocyclic compound and pest control agent
Inventor: IWATA JYUN
IPC: C07D261/04
Filed: 2008-08-11
Abstract: The present invention relates to a nitrogen-containing heterocyclic compound or salt thereof, represented by the following formula (I), and a pest control agent containing the compound or salt thereof, as an active ingredient of the pest control agent:   (see formula I) (wherein, R0 represents a halogen atom, or the like; Z represents an unsubstituted or substituted aryl group, or the like; Y represents a nitro group, or the like;  n represents an integer of 0 to 3; D represents a 5-membered to 8-membered hydrocarbon ring group or heterocyclic group; X represents a functional group represented by the following formula (II)-1 or formula (II)-2:   (see formula (II)-1)  (see formula (II)-2) (wherein, in the formula (Il)-I, the dotted line represents a single bond or double bond, and R1 and R2 respectively and independently represent a hydrogen atom, nitro group, hydroxyl group, mercapto group, unsubstituted or substituted amino group, or organic group; and, in the formula (II-2), W represents an oxygen atom or sulfur atom;  and, R11 represents a hydrogen atom, hydroxyl group, mercapto group, unsubstituted or substituted amino group, or the like); n1 represents an integer of 0 to 2;  and, A  represents a carbon atom or nitrogen atom).
Patent CA-2701477-A1 (CA)
Inventor: DOWEL TERENCE
IPC: C09K3/12
Filed: 2008-10-09
Abstract: A sealant composition for the sealing of a punctured tyre including a liquid carrier, one or more viscosity and suspending agents, one or more fillers and sealants, and one or more polyacrylates.
Patent CA-2702715-A1 (CA)
Inventor: GOFUKU HIROKI
IPC: C22B1/24
Filed: 2008-10-16
Abstract: A process for producing a pre-reduced iron which comprises: a drying step in which a raw iron oxide material selected from the group consisting of iron industry dust resulting from a steelmaking process and iron ore is dried to a given water content; a mixing step in which the raw iron oxide material which has undergone the drying step is mixed with a reducing material having a given water content to obtain a mixture; a pulverization step in which the mixture obtained in the mixing step is pulverized to 70-500 µm in terms of 80% cumulative particle diameter in sieving; a kneading step in which the water content of the mixture obtained by the pulverization step is regulated and then the mixture is kneaded; a briquetting step in which the mixture which has undergone the kneading step is briquetted to obtain briquettes; and a production step in which the briquettes obtained in the briquetting step are reduced with a rotary hearth furnace to produce a pre-reduced iron.
Patent CA-2704062-A1 (CA)
Inventor: RAPONI MITCH
IPC: C12Q1/68
Filed: 2008-10-30
Abstract: Disclosed in this specification is a method for predicting the prognosis of squamous cell lung cancer by observing regulatory changes in select miRNA sequences. These sequences may include hsa-mir-146b, hsa-mir-191, hsa-mir-206, hsa-mir-299-3p, hsa-mir-155, hsa-mir-15a, hsa-mir-122a, hsa-mir-513, hsa-mir-184, hsa-mir-511, hsa- mir-100, hsa-mir-10a, hsa-mir-453, hsa-mir-379, hsa-mir-202, hsa-mir-21, hsa-mir-126, hsa-mir-494, hsa-mir-432, hsa-mir-370, and combinations of these sequences.
Patent CA-2704360-A1 (CA)
Inventor: STARRETT JOHN E JR
IPC: A61K31/4245
Filed: 2008-10-14
Abstract: The present invention provides a novel alpha-(N-sulfonamido)acetamide compound, its pharmaceutical composition, processes thereof and a method for the treatment of Alzheimer's disease and other conditions associated with .beta.- amyloid peptide.
Patent CA-2704763-A1 (CA)
Inventor: KUNEZLER HANSRUEDI
IPC: A61M39/10
Filed: 2008-10-24
Abstract: The device according to the invention for connecting a suction hose (3) has a connecting piece (10) which is designed in such a way that the suction hose (3) can be pushed over a region of the connecting piece (10) in a sealing manner. The device also comprises a sleeve (2) which can be pushed over the aforementioned region of the connecting piece (10), at least partially covering said piece and leaving room between the sleeve (2) and the connecting piece (10) for the suction hose (3).  The connection between the sleeve (2) and the connecting piece (10) can only be separated by the destruction of at least one of said two parts. The design of the exterior of the sleeve (2) prevents a second suction hose from lying in a sealing manner against the sleeve (2). A suction hose (3) that is connected in a sealing manner to the claimed device can therefore not be removed without destroying the device.  In addition, it is impossible to push a hose with a greater diameter onto the sleeve (2) in a sealing manner.
Patent CA-2704956-A1 (CA)
Inventor: HARTH EVA M
IPC: C08L63/08
Filed: 2008-11-05
Abstract: In one aspect, the invention relates to polymers, crosslinked polymers, functionalized polymers, nanoparticles, and functionalized nanoparticles and methods of making and using same. In one aspect, the invention relates to degradable polymer and degradable nanoparticles. In one aspect, the invention relates to methods of preparing degradable nanoparticles and, more specifically, methods of controlling particle size during the preparation of degradable nanoparticles. In one aspect, the degradable nanoparticles are useful for complexing, delivering, and releasing payloads, including pharmaceutically active payloads. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Patent CA-2707693-A1 (CA)
Inventor: DUFFY ROBERT J
IPC: A61M5/14
Filed: 1998-06-09
Abstract: A modular patient care system (100) having a central management unit module, and one or more detachable functional units (104), is described. Using unique mechanical, and electrical features the modular patient care system is capable of flexibly, bilaterally, safely providing electrical power from the central management unit to the attached functional units with exposed power leads of end units being electrically isolated for safety, and security. Functional units are capable of detecting the presence of other functional units more distant from the central management unit for passing power to those units, and for otherwise electrically isolating exposed power leads when no further units are attached. The modular patient care system (100) provides for a modular connection arrangement wherein modules are detachably connected to each other in a convenient, flexible, interchangeable secured manner by providing a hinge connector pair, a specially located latch mechanims, and a guide means between any pair of modules.
Patent CA-2709380-A1 (CA)
Title: Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neural and glial tumors of the brain
Inventor: GOLDMAN STEVEN A
IPC: A61K39/395
Filed: 2008-12-22
Abstract: The present invention is directed to methods of treating a primary brain tumor and preventing the migratory spread of a primary brain tumor in a subject. These methods involve utilizing the CD24 surface protein selectively expressed on tumor progenitor cells as a therapeutic target as well as a means for directing oncolytic therapeutics directly to the tumor site. The present invention further relates to methods of diagnosing the presence of a brain tumor and monitoring the status of the brain tumor in a subject based on CD24 expression in tumor progenitor cells.
Patent CA-2710419-A1 (CA)
Title: Computer implemented scheduling systems and associated methods
Inventor: BELENKY GREGORY
IPC: G06Q10/00
Filed: 2008-10-17
Abstract: Computer implemented scheduling systems and associated methods are disclosed.  In one embodiment, a method for deriving a roster includes generating a roster within the operational constraint by assigning a plurality of workers to a plurality of individual shifts; calculating a value of the operational outcome based on the assigned shifts in the roster; calculating an overall fatigue value for the assigned individual workers based on the assigned shifts in the roster; and determining whether the generated roster is optimized based on the calculated value of the operational outcome and the overall fatigue value of the workers.
Patent CA-2711372-A1 (CA)
Title: Method and system for regulation of cooling capacity of a cooling system based on a gas expansion process.
Inventor: NILSEN INGE L
IPC: F25J1/02
Filed: 2008-12-05
Abstract: A method and associated system for regulation of the cooling capacity of a cooling system that uses a gas expansion cooling circuit where the cooling principle is expansion of one or more gaseous cooling medium streams from a higher pressure to a lower pressure are described,, characterised by the following steps:  - reducing the amount of cooling medium which is circulated in the cooling circuit (100) temporarily in that a fraction of gaseous cool-ing medium is pre-cooled at a higher pressure and is extracted from the cooling circuit (100), - expanding the fraction of cooled gaseous cooling medium across an expansion device (102) to a lower pres-sure so that at least one part of liquid cooling medium separates, - separating the liquid from the non-condensed gas for temporary storage in a storage unit (104) so that the liquid is temporarily not circulated in the otherwise closed cooling circuit (100), - thereafter to return temporarily stored gaseous cooling medium from the stor-age unit (104) to the cooling circuit (100) according to need, and -returning non-condensed gas and evaporated cooling medium from the storage unit (104) to a suitable location in the cooling circuit (100). A system to reduce the cooling capacity of a cooling instal-lation based on gas expansion cooling, is also described.
Patent CA-2712018-A1 (CA)
Inventor: OTSUBO TOSHIFUMI
IPC: A61F13/49
Filed: 2008-12-16
Abstract: The present invention aims to provide a pants type disposable diaper free from noticeable gathers formed on the innermost side of the crotch region.     In the crotch region of the pants type disposable diaper, the bodily fluid-absorbent core 26 is sandwiched between the liquid-permeable inner sheet 23 and the liquid-impermeable outer sheet 24. Further inside the inner sheet 23, the innermost sheet 21 is provided and this innermost sheet 21 prevents the inner sheet 23 from coming in contact with the wearer's skin. The innermost sheet 21 is joined, in the regions extending in the vicinity of the ends thereof opposite in the front-back direction A, to at least one of the inner sheet 23 and the outer sheet 24. The innermost sheet 21 includes, in its region defined on the transverse center line P of the diaper 1, the tuck 36 extending downward toward the inner sheet 23.
Patent CA-2714674-A1 (CA)
Title: Dapsone to treat rosacea
Inventor: GARRETT JOHN STEVEN
IPC: A61K8/02
Filed: 2008-02-27
Abstract: The methods described herein provide treatment of rosacea using topical formulations of dapsone. The methods also provide treatment of rosacea with topical dapsone in combination with other active agents, including metronidazole. The methods avoid negative hematologic side effects, including hemolysis and hemolytic anemia, that are associated with oral administration of dapsone.
Patent CA-2714977-A1 (CA)
Inventor: MCCORD DAVID A
IPC: B05D5/00
Filed: 2009-03-19
Abstract: Methods and compositions for coating a substrate with at least a basecoat layer and clearcoat layer allow quick repairs to damaged vehicle panels under ambient temperatures and without requirement of actinic or thermal radiation to cure the layers. At least one basecoat and one clearcoat layer may be applied to a substrate and the clearcoat layer may be buffed with less than 30 minutes allocated to curing the basecoat and clearcoat layers, under ambient conditions, prior to buffing. Methods and compositions are also taught for coating a substrate with at least a primer layer, a basecoat layer, and a clearcoat layer, in which the clearcoat layer may be buffed with less than about 45 minutes allocated to curing the primer, basecoat and clearcoat layers, under ambient conditions, prior to buffing.
Patent CA-2715288-A1 (CA)
Title: Compositions et procedes pour l'implantation de tissu adipeux et de produits de tissu adipeux
Inventor: ROSSEN GEDGE
IPC: A61K35/35
Filed: 2009-02-11
Abstract: L'invention porte sur des compositions et des procédés pour la préparation de biomatières biocompatibles à partir de tissu adipeux. Les biomatières biocompatibles sont des biomatières cellulaires ou acellulaires. L'invention porte en outre sur des procédés d'utilisation des biomatières biocompatibles.
Patent CA-2717063-A1 (CA)
Inventor: NAKANO SATOSHI
IPC: C07C331/30
Filed: 2009-02-27
Abstract: Disclosed is a novel method for producing a corresponding isothiocyanate compound having a carboxyl group from an amino compound having a carboxyl group. Specifically disclosed is a method for producing an isothiocyanate compound having a carboxyl group and represented by formula (2), wherein an amino compound having a carboxyl group and represented by formula (1) (wherein A represents a C6-14 aromatic hydrocarbon group, a C1-12 saturated hydrocarbon group or the like, and B represents a single bond, a C6-14 aromatic hydrocarbon group, a C1-12 saturated hydrocarbon group or the like) is reacted, in a solvent, with carbon disulfide (CS2) and then with a halogen as a simple substance.  (1)(2)